Literature DB >> 6102950

Calcitonin-producing pancreatic somatostatinoma.

J P Galmiche, J A Chayvialle, P M Dubois, L David, F Descos, C Paulin, T Ducastelle, R Colin, Y Geffroy.   

Abstract

A pancreatic somatostatinoma metastatized to the liver was detected in a 70-yr-old woman presenting with chronic diarrhea, steatorrhea, pancreatic insufficiency, diabetes mellitus, and achlorhydria. At immunocytochemistry, most tumor cells stored both somatostatin and calcitoninlike substances. Chromatography of acid extracts of the tumor on G50 Sephadex gave two distinct peaks coeluting with cyclic ovine somatostatin and human calcitonin, respectively, thus ruling out the hypothesis of a single cross-reacting molecule synthetized by the neoplastic cells. When the tumor was extracted at neutral pH, larger molecular forms of the above components were found, which accounted for less than 20% of the total immunoreactivity. Gel permeation of plasma showed that the circulating calcitonin- and somatostatinlike components consisted of three and four different forms, respectively, including components of molecular weights similar to those of the reference peptides. Inhibition curves and immunoadsorption experiments indicated that the large forms were immunologically similar, if not identical, to the corresponding standard preparations. The present case illustrates the occasional ability of neoplastic somatostatin cells of pancreas to synthetize simultaneously components immunologically related to somatostatin and calcitonin. These two inappropriate secretions could account for the symptoms displayed by this patient.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102950

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Colocalization of pancreatic polypeptide and insulin in secretory granules of a pancreatic endocrine neoplasm.

Authors:  Simon J Raphael; N Wilson Rodger; Doug Geddes B S
Journal:  Endocr Pathol       Date:  1992-09       Impact factor: 3.943

2.  Pancreatic endocrine tumours associated with WDHA syndrome. An immunohistochemical and electron microscopic study.

Authors:  A Ooi; T Kameya; M Tsumuraya; K Yamaguchi; K Abe; Y Shimosato; N Yanaihara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

3.  Somatostatinoma--the most recently described pancreatic islet cell tumor.

Authors:  C Reynolds; R Pratt; C Chan-Yan; W Boyko; W MacDonald; N Schmidt; R Rudland
Journal:  West J Med       Date:  1985-03

4.  Localization and peptide content of endocrine pancreatic tumors.

Authors:  H Mårtensson; G Böttcher; F Sundler; A Nobin
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

Review 5.  Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.

Authors:  Silvia Uccella; Annika Blank; Roberta Maragliano; Fausto Sessa; Aurel Perren; Stefano La Rosa
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

6.  Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma.

Authors:  J M Conlon; L Grimelius; L Thim
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

Review 7.  Morphological and functional investigations of neuroendocrine tumors of the pancreas.

Authors:  Philippe L Pereira; Jakub Wiskirchen
Journal:  Eur Radiol       Date:  2003-05-06       Impact factor: 5.315

8.  Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects.

Authors:  V Schusdziarra; D Grube; H Seifert; J Galle; H Etzrodt; W Beischer; O Haferkamp; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1983-07-15

9.  A new hypothalamic substance, and not luteinizing hormone-releasing hormone, is detected immunocytochemically by antibody to luteinizing hormone-releasing hormone.

Authors:  L A Sternberger; J L Greenwald; D Hock; K Elger; W G Forssmann
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  Clinicopathological Data and Treatment Modalities for Pancreatic Somatostatinomas.

Authors:  Aikaterini Mastoraki; Dimitrios Schizas; Eleni Papoutsi; Vasiliki Ntella; Prodromos Kanavidis; Athanasios Sioulas; Marina Tsoli; Georgios Charalampopoulos; Michail Vailas; Evangelos Felekouras
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.